Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock?

Aquestive Therapeutics (AQST) shares surged 14.8% on September 22, 2025, prompting market analysis into the stock's potential for further upside.

Analysis

Aquestive Therapeutics (AQST) experienced a significant price appreciation on September 22, 2025, with its stock soaring 14.8%. This sharp upward movement is accompanied by a strongly positive sentiment score of 0.75 and a bullish tone, reflecting a very favorable market reaction. The source article's title explicitly questions the potential for further upside, suggesting that the analysis is focused on the sustainability of this rally rather than just reporting the event. The underlying themes of company fundamentals, market technicals, and analyst insights indicate that the evaluation of AQST's prospects is multifaceted, incorporating both intrinsic value drivers and the current dynamics of investor positioning and sentiment.